Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Host-pathogen interactions in sepsis.

Tom van der Poll1, Steven M Opal

  • 1Academic Medical Centre, University of Amsterdam, Centre for Infection and Immunity-Amsterdam, Netherlands. t.vanderpoll@amc.uva.nl

The Lancet. Infectious Diseases
|December 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pilot study of an anti-endotoxin Ig-enriched bovine colostrum to prevent experimental sepsis.

Innate immunity·2021
Same author

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock.

International journal of molecular sciences·2021
Same author

Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.

Lancet (London, England)·2020
Same author

Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia.

Antimicrobial agents and chemotherapy·2020
Same author

Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure".

mBio·2020
Same author

Activating Immunity to Fight a Foe - A New Path.

The New England journal of medicine·2020
Same journal

Expert consensus on case definitions in human loiasis: a Delphi study.

The Lancet. Infectious diseases·2026
Same journal

The Bundibugyo virus disease outbreak: a warning signal for risks to health workers.

The Lancet. Infectious diseases·2026
Same journal

Trials of medical countermeasures to begin in DR Congo.

The Lancet. Infectious diseases·2026
Same journal

Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trial.

The Lancet. Infectious diseases·2026
Same journal

Context matters: WHO-recommended tools in combinations validated for community tuberculosis screening.

The Lancet. Infectious diseases·2026
Same journal

Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

The Lancet. Infectious diseases·2026
See all related articles

Sepsis involves complex host-pathogen interactions, not just inflammation. Understanding these dynamics, including microbial virulence and immune responses, is key to developing new sepsis treatments.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Sepsis mortality was once attributed solely to hyperinflammation.
  • Current understanding recognizes sepsis as a complex interplay of inflammation and immune suppression.

Purpose of the Study:

  • To review current knowledge on microbial pathogenesis in sepsis.
  • To explore host-pathogen interactions during sepsis development.
  • To summarize the development of potential therapeutics based on these interactions.

Main Methods:

  • Review of current scientific literature on sepsis.
  • Analysis of microbial virulence factors and host immune responses.
  • Examination of signaling pathways between pathogens and hosts.

Related Experiment Videos

Main Results:

  • Sepsis involves integrated, antagonistic processes including inflammation and immune suppression.
  • Microbial factors like virulence and bacterial load significantly impact sepsis outcomes.
  • Pathogen communication and sensing of host vulnerabilities are crucial.

Conclusions:

  • Host-pathogen interactions are central to sepsis pathogenesis.
  • Understanding these complex dynamics is essential for novel therapeutic strategies.
  • Future treatments may target microbial virulence and host immune modulation.